Triptorelin market is estimated to be US$ 16.9 billion by 2030 with a CAGR of 21.35% during the forecast period

The Triptorelin market is poised for significant growth, according to a recent market analysis report. Triptorelin, a synthetic peptide analog of gonadotropin-releasing hormone (GnRH), has gained prominence in the healthcare sector for its applications in the treatment of various conditions. Triptorelin’s effectiveness in managing hormone-related disorders, including prostate cancer, endometriosis, and precocious puberty, has driven […]